Termination of Lek's antibiotic production in Prevalje final
Prevalje, 31 May - Lek, the Slovenian subsidiary of pharma company Novartis, confirmed on Wednesday the discontinuation of antibiotic production at its facility in Prevalje. Some of the approximately 200 employees will be relocated to nearby Slovenj Gradec, with talks with social partners starting immediately.
Prevalje
Lek's additional production facility for broad-spectrum antibiotics, a EUR 150-million investment which has been aborted.
Photo: Vesna Pušnik Brezovnik/STA
File photo
The rest of this news item is available to subscribers.
The news item consists of 1.261 characters (without spaces) or 239 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.